Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the safety of the compound sulforaphane that boosts the activity of antioxidant genes in the body to combat oxidative stress. Oxidative stress has been shown experimentally to play a role in kidney disease. This drug has been tested in patients with breast cancer who have normal kidney function, but has never been tested in patients with kidney disease. In this study, the investigators will establish a safe dose for patients with chronic kidney disease based on blood levels achieved in patients with normal kidney function.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05153174
Study type Interventional
Source University of Rochester
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 2, 2022
Completion date June 8, 2023

See also
  Status Clinical Trial Phase
Completed NCT05630729 - Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management N/A
Completed NCT03293446 - AC/DC Study: Acidification Test in Patients With Chronic Kidney Disease and Healthy Controls N/A
Completed NCT04858854 - Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2 N/A
Completed NCT05624840 - Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir
Recruiting NCT05489120 - Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD) N/A
Completed NCT04207203 - Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study N/A
Completed NCT05042206 - Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease Phase 1
Recruiting NCT03582982 - Flywheel Exercise for CKD N/A
Not yet recruiting NCT06094920 - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial Phase 4
Not yet recruiting NCT03348839 - Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease N/A
Recruiting NCT04913272 - Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV Phase 2
Recruiting NCT04330807 - Physiopathology of Neuromuscular Function Related to Fatigue in Chronic Renal Disease N/A
Completed NCT05931978 - Effect of a CKD Dashboard on Patient Activation and Shared Decision Making N/A
Recruiting NCT05543928 - Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism Phase 3
Active, not recruiting NCT06037265 - PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System N/A
Completed NCT04617431 - Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients N/A
Recruiting NCT04336033 - Validation and Evaluation of a Newly Developed Mobile Diet App N/A
Recruiting NCT05138419 - A Pragmatic Approach to CKD Patient Education N/A
Not yet recruiting NCT06394544 - Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment N/A
Recruiting NCT01410617 - The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass Phase 2/Phase 3